All systems operational
Q3 2026

From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes

Joseph Van Galen · Jared A. Daar · Usama Gergis · Henry Fung
10.4103/hemoncstem.hemoncstem-d-26-00026 388 Views 0 Citations
0
Citations
388
Views
Abstract not available for this publication.
Cite this Article (APA)
Joseph, V. G., Jared, A. D., Usama, G., Henry, F. (2026). From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.4103/hemoncstem.hemoncstem-d-26-00026
Related Papers
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Ghada M. ElGohary; Shahrukh Hashmi; Jan Styczynski; Mohamed A. Kharfan-Dabaja; R · 2022
80
cites
398
Molecular mediators of breast cancer metastasis
Ragini Yeeravalli; Amitava Das · 2021
39
cites
388
Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia
Nosha Farhadfar; Ying Li; William S. May; Carolyn Brooke Adams · 2021
38
cites
392
Acute upper limb ischemia in a patient with COVID-19
Parminder Kaur; Firas Qaqa; Amr Ramahi; Yezin Shamoon; Monisha Singhal; Fayez Sh · 2021
35
cites
389
Access
View Full Text via DOI
Published in
ISSN 1658-3876
Quartile Q3
AMS Score 72
Field Medicine & Health Sciences
Publisher Elsevier / King Faisal Specialist H
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 28 Jul 2026